GlassScriptPhysician profile
Bertrand P Cole
NPI 1184618852
$2,707.34
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
See the full distribution for Addiction Medicine (Preventive Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,440 · 2020: $193 · 2023: $74.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $74.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $74.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,589.68 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $220.61 | 2019-2020 | |
| Indivior INC. | $168.14 | 2019-2023 | Sublocade |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.99 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $88.24 | 2019 | |
| Janssen Pharmaceuticals, INC | $62.23 | 2019 | |
| Amgen INC. | $60.88 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $57.65 | 2019 | |
| Lilly USA, LLC | $52.19 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $50.54 | 2019-2020 | |
| Glaxosmithkline, LLC. | $42.92 | 2019 | |
| Biodelivery Sciences International, INC. | $36.53 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $28.40 | 2019 | |
| Shionogi INC | $27.11 | 2019 | |
| Abbvie INC. | $26.00 | 2023 | Vraylar |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $22.98 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.06 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.33 | 2019 | |
| Pernix Therapeutics Holdings, INC. | $13.97 | 2019 | |
| Kaleo, INC. | $13.89 | 2019 | |
| Eisai INC. | $12.00 | 2020 |
8 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bertrand Cole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.